Inventor · disambiguated record
Qun Yin
Also filed as: YIN QUN
30 granted patents·18 pending applications·733 citations·filing 1996–2025
97Inventor score
Top patents by PatentIndex Score
48 records- 0197US9840493B2Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Dec 12, 2017·24 cites·9 claims
- 0297US7084245B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2004·Granted Aug 1, 2006·181 cites·72 claims
- 0397US6251864B1Peptides and compounds that bind to a receptorGLAXO GROUP LTD·Filed 2000·Granted Jun 26, 2001·146 cites·31 claims
- 0495US5869451APeptides and compounds that bind to a receptorGLAXO GROUP LTD·Filed 1996·Granted Feb 9, 1999·206 cites·20 claims
- 0594US6506362B1Labeled compounds that bind to a thrombopoietin receptorGLAXO GROUP LTD·Filed 2001·Granted Jan 14, 2003·39 cites·16 claims
- 0692US10442789B2Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 15, 2019·4 cites·11 claims
- 0790US8377880B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2012·Granted Feb 19, 2013·9 cites·2 claims
- 0888US6121238APeptides and compounds that bind to a receptorGLAXO WELLCOME INC·Filed 1999·Granted Sep 19, 2000·57 cites·14 claims
- 0987US9701712B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2016·Granted Jul 11, 2017·4 cites·17 claims
- 1086US8999932B2Therapeutic agents for reducing parathyroid hormone levelsKARIM FELIX·Filed 2010·Granted Apr 7, 2015·7 cites·30 claims
- 1185US7414105B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2005·Granted Aug 19, 2008·6 cites·13 claims
- 1284US9278995B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2013·Granted Mar 8, 2016·4 cites·41 claims
- 1384US7528104B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2004·Granted May 5, 2009·15 cites·47 claims
- 1484US2024116983A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1583US10344765B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2017·Granted Jul 9, 2019·2 cites·15 claims
- 1682US9820938B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2014·Granted Nov 21, 2017·3 cites·15 claims
- 1782US9567370B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·2 cites·28 claims
- 1881US7855175B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2008·Granted Dec 21, 2010·3 cites·12 claims
- 1979US8017583B2Methods of use of epsilon inhibitor compounds for the attenuation of painKAI PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·2 cites·18 claims
- 2078US2024254163A1Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2177US8304391B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2009·Granted Nov 6, 2012·2 cites·29 claims
- 2276US11162500B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2019·Granted Nov 2, 2021·0 cites·88 claims
- 2376US2025163103A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2475US8492346B2Methods of use of epsilon inhibitor compounds for the attenuation of painMACLEAN DEREK·Filed 2011·Granted Jul 23, 2013·2 cites·17 claims
- 2574US11959486B2Stable liquid formulation of AMG 416 (etelcalcetide)AMGEN INC·Filed 2021·Granted Apr 16, 2024·0 cites·13 claims
- 2674US2020399309A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2772US10844090B2Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2016·Granted Nov 24, 2020·1 cites·16 claims
- 2872US7919118B2Spacer moiety for poly (ethylene glycol) modified peptide based compoundsAFFYMAX INC·Filed 2004·Granted Apr 5, 2011·1 cites·44 claims
- 2970US8729030B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Granted May 20, 2014·1 cites·22 claims
- 3070US2019194252A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3170US2020010450A1Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3269US11866515B2Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2020·Granted Jan 9, 2024·0 cites·12 claims
- 3367US10280198B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2017·Granted May 7, 2019·0 cites·9 claims
- 3464US2017114095A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3563US2025034277A1Method for preventing and/or treating thromboembolic diseasesSUZHOU ALPHAMAB CO LTD·Filed 2022·Application pending·0 cites
- 3657US2008108564A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2007·Application pending·0 cites
- 3757US2013244939A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 3857US2013130979A1Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 3956US2013281380A1Methods of use of epsilon inhibitor compounds for the attenuation of painKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4055US2005107297A1Novel poly(ethylene glycol) modified compounds and uses thereofFiled 2004·Application pending·0 cites
- 4154US7482433B2Peptides and compounds that bind to the IL-5 receptorAFFYMAX INC·Filed 2006·Granted Jan 27, 2009·0 cites·14 claims
- 4254US2008090760A2Compositions and Methods for Inhibiting Cellular ProliferationHEMBROUGH TODD·Filed 2006·Application pending·0 cites
- 4353US7109299B1Peptides and compounds that bind to the IL-5 receptorAFFYMAX INC·Filed 1999·Granted Sep 19, 2006·12 cites·24 claims
- 4452US2013012685A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 4551US8592365B2Spacer moiety for poly(ethylene glycol) modified peptide based compoundsHOLMES CHRISTOPHER P·Filed 2011·Granted Nov 26, 2013·0 cites·10 claims
- 4650US2011282029A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
- 4749US2009005292A1Novel Peptides that Bind to the Erythropoietin ReceptorAFFYMAX INC·Filed 2005·Application pending·0 cites
- 4841US2012157660A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qun Yin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →